Dr. Jianmin Cui's lab at Washington University focuses on understanding how specific mutations in the BK potassium channel affect brain activity and contribute to neurological disorders like epilepsy and movement disorders. By studying these mutations, the lab aims to develop targeted treatments that can better address the symptoms associated with these conditions. The research combines molecular biology, electrophysiology, and drug design to improve diagnosis and treatment options for patients with these genetic variants.

Dr. Linda J. Richards' lab focuses on understanding how brain activity patterns in early life influence the development of brain circuits and overall brain function. Using the fat-tailed dunnart, a small marsupial, her team investigates when and how patterns of spontaneous neural activity emerge during development. This research provides insights into the relationships between neural activity, brain structure, and behavior, potentially informing therapeutic strategies for brain disorders.

Dr. Sheila A Stewart's lab at Washington University focuses on understanding how specific types of cells in the breast cancer environment, especially senescent cancer-associated fibroblasts (senCAFs), contribute to the progression of breast cancer. By studying the interactions between these cells and tumor cells, the lab seeks to uncover new strategies for improving cancer treatments. Their research aims to reveal how senCAFs alter the immune response and the physical properties of the tissue around tumors, potentially opening avenues for innovative therapies.

Dr. Aimilia Gastounioti's lab is focused on improving breast cancer risk assessment, particularly for Black women who are disproportionately affected by the disease. By utilizing digital breast tomosynthesis and advanced deep learning techniques, the lab aims to create robust risk prediction tools that can personalize screening and prevention strategies. This research strives to ensure that risk assessments are more accurate and applicable across diverse populations, ultimately contributing to better health outcomes and reduced mortality rates from breast cancer.

Dr. Jonathan R. Brestoff's lab at Washington University focuses on understanding how immune cells, especially neutrophils, regulate brown adipose tissue (BAT) function and thermogenesis, potentially influencing metabolic diseases like obesity and type 2 diabetes. Additionally, his research explores intercellular mitochondria transfer as a novel therapeutic approach for treating Leigh Syndrome, a serious mitochondrial disease. The lab aims to uncover mechanisms that could lead to new treatments for these conditions.

Dr. David Piston's lab at Washington University focuses on understanding and developing treatments for diabetes and autoimmune diseases. They are particularly interested in how proteins from brown fat can regulate insulin levels and glucagon secretion to improve diabetes management. Additionally, they study the role of specific ion channels in the immune response, which could lead to new therapies for chronic inflammation and cancer.

Dr. Peter M. Burgers' lab focuses on understanding how DNA replication works in cells and what happens when this process goes wrong. They use yeast as a model organism to investigate the mechanisms behind DNA replication, the consequences of errors in this process, and how cells respond to such errors. The aim is to uncover the intricate details of these pathways which are essential for maintaining genetic integrity and preventing diseases like cancer.

Dr. Benjamin A Garcia's lab at Washington University focuses on understanding complex biological processes related to cardiovascular health and neurological development using cutting-edge chemical biology approaches. The lab investigates the role of specific protein modifications in heart development and disease, as well as how epigenetic mechanisms influence neurological disorders. By employing advanced mass spectrometry and innovative research techniques, they aim to uncover new therapeutic strategies and improve our understanding of critical cellular functions.

Dr. Kodi S. Ravichandran's lab at Washington University focuses on how certain molecules in our cells help with communication and the removal of dying cells, which is crucial in maintaining health. Their research explores how these processes affect cell differentiation, particularly in fat cells, and how specialized proteins in immune cells help manage the cleanup of cellular debris during inflammation. Through their work, they hope to uncover new insights that could lead to better treatments for conditions like obesity and inflammatory diseases.

Dr. Hua Li's research focuses on improving the treatment of cervical cancer by utilizing advanced imaging techniques and RNA analyses. The goal is to develop personalized treatment strategies by predicting how well individual tumors will respond to therapy. The lab combines data from various sources, such as imaging and genetic information, to create robust models that can aid in clinical decision-making and improve patient outcomes.

Dr. Jin Zhang's lab at Washington University focuses on improving treatment outcomes for cervical cancer patients by developing predictive biomarkers and understanding the biology behind treatment resistance. Their research combines genomics and imaging techniques to identify patients at risk of treatment failure and to detect cancer recurrence early using advanced analytical methods. By integrating multi-omics data, the lab aims to personalize cancer therapy and enhance patient care.

Dr. Julie Kristina Schwarz's lab focuses on improving radiation therapy for cervical cancer by targeting the metabolism of glutamine, an amino acid crucial for cancer cell growth. The research aims to enhance anti-tumor immunity and increase the effectiveness of radiation treatment by combining it with a drug that inhibits glutamine metabolism. Through both laboratory studies and clinical trials, the lab works to develop innovative strategies for treating radiation-resistant cervical cancers.

Dr. Ganesh Chand's lab focuses on understanding Alzheimer's disease and its effects on brain function and behavior. Using advanced machine learning techniques, the lab studies the relationships between brain imaging markers, neuropsychiatric symptoms, and genetic factors in Alzheimer's patients and healthy controls. The goal is to uncover how different biological markers correlate with symptoms and identify distinct subgroups of patients, ultimately aiding in more personalized treatment approaches for the disease.

Dr. Kyunghee Choi's lab focuses on understanding how a specific protein called Myct1 influences both blood vessel formation and the immune response to tumors. By studying endothelial cells, which line the blood vessels, the lab aims to uncover how Myct1 can either promote angiogenesis (the formation of new blood vessels) or enhance the immune attack on tumors. The ultimate goal is to leverage these insights to develop new cancer therapies that improve immune responses while inhibiting abnormal blood vessel growth.

Dr. Camillo Padoa-Schioppa's lab at Washington University focuses on understanding how the brain makes economic choices. By studying neuronal activity in the orbitofrontal cortex of monkeys, the lab investigates how decisions are influenced by various factors such as the number of available options and the internal state of the individual. This research is important for gaining insights into neurological disorders that disrupt economic choice behavior, like frontotemporal dementia and major depression.

Dr. Erik Herzog's lab at Washington University focuses on understanding how our body's internal clock, known as the circadian clock, adjusts to environmental changes, like the length of day and night. Through a blend of experimental techniques and computer modeling, the research aims to uncover how specific brain cells communicate and alter their connections to maintain daily rhythms in behavior and physiology. This work is crucial for revealing how the brain functions as a network and adapts to seasonal variations.

Dr. Rui Zhang's lab at Washington University focuses on studying the structure and function of a vital organelle, the conoid, in the Toxoplasma gondii parasite. By examining the unique complexities of this structure, the lab aims to unlock insights that could contribute to developing more effective treatments for diseases caused by apicomplexan parasites. This research is crucial as it addresses significant gaps in our understanding of these pathogens, which are responsible for severe human health issues.

Joseph Corbo's lab is focused on understanding and treating retinal degeneration, particularly retinitis pigmentosa, a common cause of blindness. The lab explores innovative therapies that knock out specific genes to prevent the degeneration of photoreceptors, which are essential for vision. By utilizing advanced techniques such as CRISPR and examining multiple animal models, the lab aims to develop strategies that might help a wide range of genetic forms of blindness.

Dr. Joseph P. Culver's lab focuses on developing innovative optical imaging techniques to study brain development in children, particularly those with autism spectrum disorder (ASD). By creating a lightweight imaging system that allows for naturalistic brain mapping, his research aims to improve early detection of brain function alterations associated with ASD, which is crucial for timely intervention and better outcomes.

Dr. Siyuan Ding's research lab focuses on understanding how rotaviruses, a leading cause of severe diarrhea in infants and children, spread between cells and evade the immune system. By investigating specific viral proteins' interactions with host cell components, the lab aims to uncover new ways to improve vaccines and develop effective antiviral treatments against rotavirus infections. Their work combines advanced techniques from microbiology and immunology to address significant health challenges, especially in vulnerable populations.